Andrographis flu remedies recalled across Australia over severe allergy risk
The regulator says reports of severe allergic reactions have stayed high. One case was fatal.
Popular cold and flu medicines with the herb andrographis have been recalled across Australia. The regulator is the Therapeutic Goods Administration (TGA).
The TGA says these medicines will no longer be listed as low-risk products. Reports of anaphylaxis have stayed high since a large rise in 2019.
Anaphylaxis is a severe allergic reaction. A fatal case was reported in June 2024.
Andrographis is a herb. It is often used in Chinese and Indian traditional medicine for flu and colds.
It is often sold without a prescription at pharmacies, health food shops and supermarkets. Products including BioCeuticals Armaforce and Clinical ImmuneForce have been recalled, along with several others.
The TGA will start taking action against retailers that have not recalled the products from mid-October.
- Eight, including BioCeuticals Armaforce
- Products recalled
- 1 September
- Announced
- June 2024
- Fatal case reported
- Therapeutic Goods Administration
- Regulator
Why it mattersThe TGA says a delay would likely pose an immediate or serious risk of injury to consumers.
AustraliaRetailers across Australia face action from the Therapeutic Goods Administration starting mid-October if they have not recalled these products.
Corroborated bythenightly.com.au
✓ Claims checked against the source and corrected before publish. checked 2 h ago
Open this story in InSnip →
